Molnupiravir speeds up recovery and eases long-term symptoms, but its minimal effect on hospitalizations raises questions about its broader impact on COVID-19 care. Study: Health outcomes 3 months ...

Molnupiravir, an antiviral drug used to treat patients with COVID-19, appears to be driving SARS-CoV-2 to mutate and evolve, with some of these new viruses being transmitted onwards, a new study has ...

Molnupiravir is the first oral antiviral treatment for Covid to report clinical trial results. The first pill designed to treat symptomatic Covid has been approved by the UK medicines regulator.

Molnupiravir was given to people twice a day, for five days at home, while they had the Omicron variant of Covid. Those chosen were at a higher risk of death or hospitalisation from Covid due to ...

Last week, the UK said it had secured 480,000 doses of molnupiravir, along with 250,00 courses of another antiviral medicine developed by Pfizer that is based on new compound PF-07321332 and a low ...

New research has found that molnupiravir offers modest longer term benefits to vaccinated adults. This is the latest outcome of the NIHR funded and delivered PANORAMIC trial, led by the University of ...

More than 13,500 people contracted COVID-19 in Connecticut between Aug. 1 and Oct. 5, according to the most recent state data ...

SWEDESBORO, N.J.--(BUSINESS WIRE)--Today, Wedgewood announces the addition of molnupiravir to its formulary. Originally developed for human viral infections, including COVID-19, molnupiravir has ...

Experts of the ICMR 's National Task Force on COVID-19 for the fourth time have unanimously rejected the inclusion of anti-viral drug Molnupiravir in the coronavirus treatment guidelines saying ...

New York, Researchers have discovered that the treatment of SARS-CoV-2 infection (Covid-19) with a new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses the virus ...

SWEDESBORO, N.J., September 18, 2024--(BUSINESS WIRE)--Today, Wedgewood announces the addition of molnupiravir to its formulary. Originally developed for human viral infections, including COVID-19, ...